Literature DB >> 29737908

Prevalence of Potential Adult Chronic Rhinosinusitis Symptoms in the United States.

Neil Bhattacharyya1, Sapideh Gilani2.   

Abstract

Objective To determine the prevalence of chronic rhinosinusitis-related symptoms in the United States. Study Design Cross-sectional analysis of a national database. Setting Representative sampling of the US adult population. Subjects and Methods The National Health and Nutrition Examination Survey data set, taste and smell supplement 2013-2014 was analyzed for sinonasal question responses regarding discolored nasal mucus, nasal blockage, sinus pain, and dysosmia. The individual prevalences as well as the prevalence of 2 or more of these symptoms (which would be compatible with a diagnosis of chronic rhinosinusitis) were determined for the US population. Results After excluding adults with an intercurrent head cold, 113.5 million adults (mean age 58.2 years; 52.6% female) were analyzed. Individual symptom prevalences were dysosmia (9.17 million, 8.1%), nasal blockage (6.9 million, 6.0%), sinus pain (2.37 million, 2.1%), and discolored mucous (1.28 million, 1.1%). Overall, 14.8 million (13.0%) adults had exactly 1 sinonasal symptom, and 2.37 million adults (2.1%) responded with 2 or more cardinal symptoms for chronic rhinosinusitis. With respect to sex, 1.9% of males reported 2 or more symptoms compatible with chronic rhinosinusitis vs 2.2% of females ( P = .690), which is not statistically significant. Conclusion Of US adults, 2.1% meet symptom criteria for the potential diagnosis of chronic rhinosinusitis at any given time. Further objective corroboration with a physical exam and determination of duration of symptoms would be required to determine the true prevalence of chronic rhinosinusitis, but this point prevalence represents the potential population at risk for chronic rhinosinusitis in the United States.

Entities:  

Keywords:  CT scan; acute rhinosinusitis; chronic rhinosinusitis; facial pain; nasal discharge; nasal endoscopy; nasal obstruction; sinusitis; upper respiratory infection

Mesh:

Year:  2018        PMID: 29737908     DOI: 10.1177/0194599818774006

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  13 in total

Review 1.  A review of dupilumab in the treatment of atopic diseases.

Authors:  Quinn Thibodeaux; Mary Patricia Smith; Karen Ly; Kristen Beck; Wilson Liao; Tina Bhutani
Journal:  Hum Vaccin Immunother       Date:  2019-03-27       Impact factor: 3.452

2.  The efficacy of itraconazole, fluticasone and doxycycline in chronic rhinosinusitis.

Authors:  Seyyed Mostafa Hashemi; Seyed Mojtaba Abtahi Forooshani; Ali Borhani
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-08-15

3.  Frequency and causes of self-medication in patients with chronic rhinosinusitis, North of Iran, 2018-2019.

Authors:  Shirin Parvinroo; Hossein Rouhi Khalkhali Pargam; Rastin Hosseinzadeh Asli; Elahe Rafiei; Shadman Nemati
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-27       Impact factor: 3.236

4.  Use of the Diet History Questionnaire III to determine the impact of dysosmia on dietary quality.

Authors:  Jordan J Allensworth; Rodney J Schlosser; Timothy L Smith; Jess C Mace; Zachary M Soler
Journal:  Int Forum Allergy Rhinol       Date:  2021-12-18       Impact factor: 5.426

5.  CRS-PRO and SNOT-22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis.

Authors:  Samuel D Racette; Alexander L Schneider; Meera Ganesh; Julia H Huang; David S Lehmann; Caroline P E Price; Samuel G Rodegherio; Abhita T Reddy; Jacob G Eide; David B Conley; Kevin C Welch; Robert C Kern; Stephanie Shintani-Smith; Atsushi Kato; Robert P Schleimer; Bruce K Tan
Journal:  Int Forum Allergy Rhinol       Date:  2022-04-01       Impact factor: 5.426

Review 6.  Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Claus Bachert; Neil Bhattacharyya; Martin Desrosiers; Asif H Khan
Journal:  J Asthma Allergy       Date:  2021-02-11

Review 7.  Current Perspective on Nasal Delivery Systems for Chronic Rhinosinusitis.

Authors:  Junhu Tai; Kijeong Lee; Tae Hoon Kim
Journal:  Pharmaceutics       Date:  2021-02-10       Impact factor: 6.321

8.  Smell and Taste Impairment in a Nationwide Sample of US Adults With Chronic Rhinosinusitis Symptoms.

Authors:  James H Kim; Janet Choi; Sophie S Jang; Bozena B Wrobel; Elisabeth H Ference
Journal:  OTO Open       Date:  2021-02-02

9.  Anaerobic Microbiota Derived from the Upper Airways Impact Staphylococcus aureus Physiology.

Authors:  Sarah K Lucas; Alex R Villarreal; Madison M Ahmad; Abayo Itabiyi; Erin Feddema; Holly C Boyer; Ryan C Hunter
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

10.  Microcurrent technology for rapid relief of sinus pain: a randomized, placebo-controlled, double-blinded clinical trial.

Authors:  Ximena A Maul; Nicole A Borchard; Peter H Hwang; Jayakar V Nayak
Journal:  Int Forum Allergy Rhinol       Date:  2019-01-22       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.